--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
ELVN Enliven Therapeutics
- 21.080
- +0.160+0.76%
Close Mar 21 16:00 ET
- 22.455
- +1.375+6.52%
Post 20:01 ET
1.03BMarket Cap-11.15P/E (TTM)
21.408High20.550Low412.59KVolume20.640Open20.920Pre Close8.67MTurnover1.56%Turnover RatioLossP/E (Static)49.00MShares30.03052wk High3.33P/B557.98MFloat Cap15.96052wk Low--Dividend TTM26.47MShs Float250.840Historical High--Div YieldTTM4.10%Amplitude3.896Historical Low21.022Avg Price1Lot Size
Enliven Therapeutics Key Stats
Enliven Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Enliven Therapeutics Earnings Reports
Read more
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data